% | $
Quotes you view appear here for quick access.

Oncolytics Biotech, Inc. Message Board

  • hgff101 hgff101 Jan 29, 2013 11:04 AM Flag

    How the picture has changed

    As you all may have noticed, while you all look to take all new data and fit it in with your existing thesis, I am always continually reassessing.

    I need to really grab you by the lapels to get you all to see something you may not have latched onto:

    In the latest presentation, I call your attention to fact that in two, not one but two trials, Reo has reached statsig tumor control (HnN and Lung).

    Do you realize what this means?

    With the safety profile and the statsig tumour control, IMHO we have already arrived at the point where Reo actually approvable for its first indication: as a neo-adjuvent to standard of care resection and possibly radiation.

    IMHO we have what we need to cross over into commercial use.

    The price is not an indicator of the potential, and in addition it shows simple consolidation off the recent rally. Again all IMHO.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.33-0.02(-5.71%)Nov 4 4:00 PMEST